Incyte today announced that the European Commission (EC) has approved Minjuvi® (tafasitamab) in combination with lenalidomide and rituximab for the treatment of adult patients with relapsed or ...

Dutch start-up VectorY Therapeutics has been given the green light by the FDA for a phase 1/2 trial of a drug against a target implicated in up to 97% of amyotrophic lateral sclerosis (ALS) cases. VTx ...

For new subscribers, there are in fact multiple free trials of Amazon Prime available. The first is the standard 30-day free trial of Amazon Prime that anyone can take advantage of. The second it is ...

Since HBO Max joined the streaming service wars, it has been a force to be reckoned with due to the extensive Warner Bros. media library. Home to culture-forming shows (Games of Thrones, The Last of ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Drs Joseph Mikhael and Shaji Kumar discuss the future of multiple myeloma, including enhanced diagnostics for detecting ...

Katherine Haan, MBA, is a Senior Staff Writer for Forbes Advisor and a former financial advisor turned international bestselling author and business coach. For more than a decade, she’s helped small ...

Insecticide-treated nets (ITNs) are the most impactful and cost-effective control tool against malaria. ITNs are primarily distributed through triennial mass campaigns across Africa, though overall ...

This study presents a valuable advance in reconstructing naturalistic speech from intracranial ECoG data using a dual-pathway model. The evidence supporting the claims of the authors is solid, ...

During this symposium, leading international epileptologists discussed the key challenges and opportunities that currently ...